Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.41 is 28% below its 5-year average of 3.33, near the low end of its 5-year range (0.55–11.05).
As of the fiscal period ended Wednesday, December 31, 2025. 13.02% below its 12-month average of 2.77.
Reported quarterly current ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 2.41.
CURRENT RATIO
2.41
CURRENT RATIO AVG TTM
2.77
CURRENT RATIO AVG 3Y
2.36
CURRENT RATIO AVG 5Y
3.33
CURRENT RATIO AVG 10Y
2.96
CURRENT RATIO AVG 15Y
2.47
CURRENT RATIO AVG 20Y
2.59
CURRENT VS TTM AVG
-13.02%
CURRENT VS 3Y AVG
+2.09%
CURRENT VS 5Y AVG
-27.57%
CURRENT VS 10Y AVG
-18.50%
CURRENT VS 15Y AVG
-2.19%
CURRENT VS 20Y AVG
-6.89%
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-35.66%
vs the sector median at left
Market Cap
$376983.00
Current Ratio
9.97
TTM Avg
8.62
3Y Avg
13.45
5Y Avg
8.98
Market Cap
$106970.00
Current Ratio
0.94
TTM Avg
1.53
3Y Avg
2.70
5Y Avg
2.29
Market Cap
$385197.00
Current Ratio
0.78
TTM Avg
0.50
3Y Avg
0.69
5Y Avg
2.39
Market Cap
$95475.00
Current Ratio
8.09
TTM Avg
12.83
3Y Avg
6.46
5Y Avg
13.32
Market Cap
$71053.00
Current Ratio
5.07
TTM Avg
1.79
3Y Avg
4.80
5Y Avg
10.47
Market Cap
$30054.00
Current Ratio
4.22
TTM Avg
1.69
3Y Avg
2.61
5Y Avg
2.27
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SciSparc Ltd. (SPRC) | $252756.00 | 2.41 | 2.77 | 2.36 | 3.33 |
| Virax Biolabs Group Limited (VRAX)vs › | $376983.00 | 9.97 | 8.62 | 13.45 | 8.98 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $106970.00 | 0.94 | 1.53 | 2.70 | 2.29 |
| Niki BioSolutions, Inc. (NIKI)vs › | $385197.00 | 0.78 | 0.50 | 0.69 | 2.39 |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | 8.09 | 12.83 | 6.46 | 13.32 |
| PRF Technologies Ltd. (PRFX)vs › | $71053.00 | 5.07 | 1.79 | 4.80 | 10.47 |
| Akanda Corp. (AKAN)vs › | $61172.00 | 0.22 | 0.98 | 0.64 | 0.52 |
| Zhongchao Inc. (ZCMD)vs › | $30562.00 | 11.11 | 11.66 | 8.94 | 8.87 |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30054.00 | 4.22 | 1.69 | 2.61 | 2.27 |
| NewGenIvf Group Limited (NIVF)vs › | $6235.00 | 3.12 | 2.15 | 1.85 | 1.56 |
Current Ratio
2.41
Quick Ratio
2.38
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 2.41 |
| 2025-06-30 | 0.55 |
| 2024-12-31 | 5.36 |
| 2024-06-30 | 1.86 |
| 2023-12-31 | 4.10 |
| 2023-06-30 | 1.17 |
| 2022-12-31 | 1.09 |
| 2022-06-30 | 1.20 |
| 2021-12-31 | 5.59 |
| 2021-06-30 | 11.05 |
| 2020-12-31 | 2.25 |
| 2020-06-30 | 0.49 |
| 2019-12-31 | 0.91 |
| 2019-06-30 | 0.68 |
| 2018-12-31 | 0.54 |
| 2018-06-30 | 5.10 |
| 2017-12-31 | 8.07 |
| 2017-06-30 | 18.58 |
| 2016-12-31 | 1.20 |
| 2016-06-30 | 2.33 |
| 2015-12-31 | 3.24 |
| 2015-06-30 | 0.90 |
| 2014-12-31 | 0.58 |
| 2014-06-30 | 2.90 |
| 2013-12-31 | 2.43 |
| 2013-06-30 | 1.91 |
| 2012-12-31 | 1.38 |
| 2012-06-30 | 0.00 |
| 2011-12-31 | 4.31 |
| 2010-12-31 | 6.50 |
| 2009-12-31 | 2.49 |
| 2008-12-31 | 6.41 |
| 2007-12-31 | 2.36 |
| 2006-12-31 | 22.84 |
